 Impel NeuroPharma, Inc. NASDAQ:IMPL Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants John Leaman - Chief Financial Business Officer Adrian Adams - Chairman of the Board Chief Executive Officer Len Paolillo - Chief Commercial Officer Conference Call Participants Ken Cacciatore - Cowen Laura Chico - Wedbush Eddie Hickman - Guggenheim Securities Operator Good morning, ladies and gentlemen, and Welcome to Impel Pharmaceuticals First Quarter 2022 Earnings Corporate Update Conference Call. At this time, all participants are in listen-only mode. 